Vitalik maps out quantum risks as Ethereum Strawmap outlines seven forks to strengthen post-quantum security, scalability, and finality.

Recursion Pharmaceuticals (RXRX) stock surged after the company significantly beat Street forecasts with its Q4 2025 results.

Recursion Pharmaceuticals shares were 11% higher, at $3.90, after the company reported fourth-quarter revenue that was higher than last year, and a loss that was narrower than last year's.

Guidance extended from year-end 2027 to early 2028, with operating expense reduction targets reiterated and achieved at a greater scale (now 35% year-over-year, 10% below guidance). Strategic focus ...

Delivered first clinical validation of the Recursion full stack AI Operating System in FAP, demonstrating translation from AI-driven biological ...

Master R-Squared calculation in Excel. Get formula tips, expert advice, and avoid errors for precise financial analysis.

We’ve found that more expensive doesn’t always mean better when it comes to multivitamins. To find the best multivitamin for men, consider the range of nutrients it provides, look for artificial ...